Clinical Trial Update: The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of natalizumab (Tysabri) on sexual dysfunction in people with multiple sclerosis; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: University of South Florida | Conditions: Multiple Sclerosis | NA | Status: COMPLETED | Results posted: 2017-03-31